Autoimmune type 1 diabetes: resolved and unresolved issues.
作者信息
Notkins A L, Lernmark A
机构信息
Experimental Medicine Section, Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-4322, USA.
出版信息
J Clin Invest. 2001 Nov;108(9):1247-52. doi: 10.1172/JCI14257.
Abstract
摘要
相似文献
1
Autoimmune type 1 diabetes: resolved and unresolved issues.
J Clin Invest. 2001 Nov;108(9):1247-52. doi: 10.1172/JCI14257.
2
Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
Diabetologia. 1999 Jan;42(1):3-14. doi: 10.1007/s001250051105.
3
Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
J Autoimmun. 2005 Mar;24(2):153-67. doi: 10.1016/j.jaut.2004.12.001.
4
Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren.
Diabetologia. 2000 Apr;43(4):457-64. doi: 10.1007/s001250051329.
5
Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Neurology. 2005 Feb 22;64(4):743-5. doi: 10.1212/01.WNL.0000151973.08426.7E.
6
Autoreactive T cells in human type 1 diabetes.
Endocrinol Metab Clin North Am. 2004 Mar;33(1):113-33, ix-x. doi: 10.1016/S0889-8529(03)00081-1.
7
Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Diabet Med. 1997 Aug;14(8):678-85. doi: 10.1002/(SICI)1096-9136(199708)14:8<678::AID-DIA451>3.0.CO;2-F.
8
Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
J Immunol. 1998 Dec 15;161(12):6963-9.
9
Selecting culprits in type 1 diabetes beta-cell killing.
J Clin Invest. 1999 Dec;104(11):1487-9. doi: 10.1172/JCI8826.
10
Dual-parameter model for prediction of type I diabetes mellitus.
Proc Assoc Am Physicians. 1998 Mar-Apr;110(2):126-35.
引用本文的文献
1
A Historical and Epistemological Review of Type 1 Diabetes Mellitus.
J Clin Med. 2025 Jul 11;14(14):4923. doi: 10.3390/jcm14144923.
2
The role of GABA in type 1 diabetes.
Front Endocrinol (Lausanne). 2024 Nov 15;15:1453396. doi: 10.3389/fendo.2024.1453396. eCollection 2024.
3
Benchmarking enrichment analysis methods with the disease pathway network.
Brief Bioinform. 2024 Jan 22;25(2). doi: 10.1093/bib/bbae069.
4
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.
Diabetes Ther. 2024 Jan;15(1):33-60. doi: 10.1007/s13300-023-01465-7. Epub 2023 Sep 26.
5
A randomized trial of oral gamma aminobutyric acid (GABA) or the combination of GABA with glutamic acid decarboxylase (GAD) on pancreatic islet endocrine function in children with newly diagnosed type 1 diabetes.
Nat Commun. 2022 Dec 24;13(1):7928. doi: 10.1038/s41467-022-35544-3.
6
The IGFBP3/TMEM219 pathway regulates beta cell homeostasis.
Nat Commun. 2022 Feb 3;13(1):684. doi: 10.1038/s41467-022-28360-2.
7
Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA.
Clin Diabetes Endocrinol. 2022 Jan 5;7(1):23. doi: 10.1186/s40842-021-00135-6.
8
Stem Cell Research Tools in Human Metabolic Disorders: An Overview.
Cells. 2021 Oct 7;10(10):2681. doi: 10.3390/cells10102681.
9
DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life.
Diabetologia. 2021 Oct;64(10):2258-2265. doi: 10.1007/s00125-021-05513-4. Epub 2021 Jul 16.
10
The importance of glycogen molecular structure for blood glucose control.
iScience. 2020 Dec 16;24(1):101953. doi: 10.1016/j.isci.2020.101953. eCollection 2021 Jan 22.
本文引用的文献
1
Autoantibodies as predictors of disease.
J Clin Invest. 2001 Nov;108(10):1417-22. doi: 10.1172/JCI14452.
2
Mechanisms for the induction of autoimmunity by infectious agents.
J Clin Invest. 2001 Oct;108(8):1097-104. doi: 10.1172/JCI14235.
3
The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals.
Diabetologia. 2001 Mar;44(3):271-85. doi: 10.1007/s001250051614.
4
The IA-2 gene family: homologs in Caenorhabditis elegans, Drosophila and zebrafish.
Diabetologia. 2001 Jan;44(1):81-8. doi: 10.1007/s001250051583.
5
The World Health Organization International Collaborative Study for islet cell antibodies.
Diabetologia. 2000 Oct;43(10):1282-92. doi: 10.1007/s001250051524.
6
The molecular specificity of insulin autoantibodies.
Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):338-53. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr145>3.0.co;2-l.
7
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.
Diabetes Care. 2000 Feb;23(2):228-33. doi: 10.2337/diacare.23.2.228.
8
A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.
N Engl J Med. 2000 Feb 3;342(5):301-7. doi: 10.1056/NEJM200002033420501.
9
Environmental factors in the pathogenesis of type 1 diabetes mellitus.
Exp Clin Endocrinol Diabetes. 1999;107 Suppl 3:S93-100. doi: 10.1055/s-0029-1212160.
10
Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group.
Eur J Immunogenet. 1999 Apr-Jun;26(2-3):117-27.
Zotero 插件